




Searching News Database: intracranial pressure
HSMN NewsFeed - 12 Dec 2022
IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit
IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit
HSMN NewsFeed - 3 Jun 2021
vasopharm GmbH Announces Results of the NOSTRA III Traumatic Brain Injury Phase III Study
vasopharm GmbH Announces Results of the NOSTRA III Traumatic Brain Injury Phase III Study
HSMN NewsFeed - 11 Aug 2020
IRRAS Announces First Global Patient Treatment with Newly Developed Hummingbird Solo ICP Monitoring System
IRRAS Announces First Global Patient Treatment with Newly Developed Hummingbird Solo ICP Monitoring System
HSMN NewsFeed - 7 Jan 2020
IRRAS Provides US Launch Update, Product Portfolio Progress and Objectives for 2020
IRRAS Provides US Launch Update, Product Portfolio Progress and Objectives for 2020
HSMN NewsFeed - 20 Apr 2017
Arkis BioSciences Expands Clinical Use Of Its New Minimally Invasive Tunneling Guidewire(TM) Technology
Arkis BioSciences Expands Clinical Use Of Its New Minimally Invasive Tunneling Guidewire(TM) Technology
HSMN NewsFeed - 7 Apr 2017
Medtronic Announces Voluntary Worldwide Recall of its StrataMR(TM) Adjustable Valves and Shunts
Medtronic Announces Voluntary Worldwide Recall of its StrataMR(TM) Adjustable Valves and Shunts
HSMN NewsFeed - 15 Jan 2016
Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
HSMN NewsFeed - 21 Oct 2013
Integra LifeSciences Introduces Next-Generation Licox(R) Brain Tissue Oxygen Monitoring System
Integra LifeSciences Introduces Next-Generation Licox(R) Brain Tissue Oxygen Monitoring System
HSMN NewsFeed - 23 Jul 2012
InnerSpace Neuro Announces Launch of New, Tunneled TBI Catheter, Abstract Presentation
InnerSpace Neuro Announces Launch of New, Tunneled TBI Catheter, Abstract Presentation
HSMN NewsFeed - 22 Jun 2010
InnerSpace Announces U.S. Market Launch of Hummingbird Neuromonitoring Line
InnerSpace Announces U.S. Market Launch of Hummingbird Neuromonitoring Line
HSMN NewsFeed - 28 Jan 2010
ZOLL Awarded Therapeutic Temperature Management Contract with HealthTrust Purchasing Group
ZOLL Awarded Therapeutic Temperature Management Contract with HealthTrust Purchasing Group
HSMN NewsFeed - 1 May 2009
Integra LifeSciences Will Feature the New LimiTorr Volume Limiting CSF Drainage System At AANS
Integra LifeSciences Will Feature the New LimiTorr Volume Limiting CSF Drainage System At AANS
HSMN NewsFeed - 25 Apr 2008
Integra LifeSciences Announces Launch of the LimiTorr Volume Limiting CSF Drainage System
Integra LifeSciences Announces Launch of the LimiTorr Volume Limiting CSF Drainage System
HSMN NewsFeed - 16 Apr 2007
Integra LifeSciences Announces New Proposed Tracking Codes for Intracranial Monitoring
Integra LifeSciences Announces New Proposed Tracking Codes for Intracranial Monitoring
HSMN NewsFeed - 13 Mar 2007
Xytis Enrolls First Patient in Phase II Clinical Study With Anatibant (XY2405) for Traumatic Brain Injury
Xytis Enrolls First Patient in Phase II Clinical Study With Anatibant (XY2405) for Traumatic Brain Injury
HSMN NewsFeed - 18 Dec 2006
Neuro Diagnostic Devices (NeuroDx) Names Industry Veteran Frederick Fritz as CEO and President
Neuro Diagnostic Devices (NeuroDx) Names Industry Veteran Frederick Fritz as CEO and President
HSMN NewsFeed - 19 Oct 2006
Gleevec(R) Approved in the US for Five Rare Life-Threatening Disorders With Limited Treatment Options
Gleevec(R) Approved in the US for Five Rare Life-Threatening Disorders With Limited Treatment Options
HSMN NewsFeed - 9 Oct 2006
Integra LifeSciences Announces Launch of the Mobius(TM) Multi Modality Monitoring System
Integra LifeSciences Announces Launch of the Mobius(TM) Multi Modality Monitoring System
HSMN NewsFeed - 7 Aug 2006
NEOPHARM Provides Update on Reimbursement Progress for CINTREDEKIN BESUDOTOX
NEOPHARM Provides Update on Reimbursement Progress for CINTREDEKIN BESUDOTOX
HSMN NewsFeed - 8 Jun 2006
NeoPharm Announces PRECISE Trial Has Reached Criteria for Interim Efficacy Analysis
NeoPharm Announces PRECISE Trial Has Reached Criteria for Interim Efficacy Analysis
HSMN NewsFeed - 10 Apr 2006
Novartis completes submissions in US and Europe for Gleevec(R) as treatment for four rare types of cancer
Novartis completes submissions in US and Europe for Gleevec(R) as treatment for four rare types of cancer
Additional items found! 21

Members Archive contains
21 additional stories matching:
intracranial pressure
(Password required)
intracranial pressure
(Password required)